TCDD induces c-jun expression via a novel Ah (dioxin) receptor-mediated p38-MAPK-dependent pathway

Oncogene

Volumn 24, Issue 31, 2005, Pages 4975-4983

  Weiss, Carsten ^a,b   Faust, Dagmar ^a   Dürk, Heike ^a   Kolluri, Siva Kumar ^b,c   Pelzer, Anke ^b,d   Schneider, Sandra ^b   Dietrich, Cornelia ^a   Oesch, Franz ^a   Göttlicher, Martin ^b,e  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^c BURNHAM INSTITUTE   (United States)

^d UNIVERSITY OF KARLSRUHE   (Germany)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Ah receptor; c jun; Cross talk; Dioxin; p38 MAP kinase; TCDD

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ANISOMYCIN; AROMATIC HYDROCARBON RECEPTOR; CYCLOHEXIMIDE; DIOXIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN C JUN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELK 1; TRANSFORMING GROWTH FACTOR ALPHA; WORTMANNIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEPHOSPHORYLATION; DNA BINDING; DOWNSTREAM PROCESSING; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; LIVER DEVELOPMENT; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

BASE SEQUENCE; CELL LINE, TUMOR; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-JUN; RECEPTORS, ARYL HYDROCARBON; RNA, NEOPLASM; RNA, SMALL INTERFERING; TETRACHLORODIBENZODIOXIN; TRANSFECTION;

EID: 23744489560     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208679     Document Type: Article

References (45)

1. Bender K, Göttlicher M, Whiteside S, Rahmsdorf HJ and Herrlich P. (1998). EMBO J., 17, 5170-5181.
2. Burbach KM, Poland A and Bradfield CA. (1992). Proc. Natl. Acad. Sci. USA, 89, 8185-8189.
3. Cavigelli M, Li WW, Lin A, Su B, Yoshioka K and Kann M. (1996). EMBO J., 15, 6269-6279.
4. Chang L and Karin M. (2001). Nature, 410, 37-40.
5. Couture L, Abbott B and Birnbaum L. (1990). Teratology, 42, 619-627.
6. De Bosscher K, Vanden Berghe W and Haegeman G. (2003). Endocr. Rev. 24, 488-522.
7. Dunlap JC. (1998). Curr. Opin. Genet. Dev., 8, 400-406.
8. Erna M, Sogawa K, Watanabe N, Chujoh Y, Matsushita N, Gotoh O, Funae Y and Fujii-Kuriyama Y. (1992). Biochem. Biophys. Res. Commun., 184, 246-253.
9. Enan E and Matsumura F. (1995). Biochem. Pharmacol., 49, 249-261.
10. Fernandez-Salguero P, Pineau T, Hubert DM, McPhail T, Lee SS, Kimura S, Nebert DW, Rudikoff S, Ward JM and Gonzalez FJ. (1995). Science, 268, 722-726.
11. Fernandez-Salguero PM, Hubert DM, Rudikoff S, Ward JM and Gonzalez FJ. (1996). Toxicol. Appl. Pharmacol., 140, 173-179.
12. Ge B, Gram H, Di Padova F, Huang B, New L, Ulevitch RJ, Luo Y and Han J. (2002). Science, 295, 1291-1294.
13. Herrlich P. (2001). Oncogene, 20, 2465-2475.
14. Hoffer A, Chang CY and Puga A. (1996). Toxicol. Appl. Pharmacol., 141, 238-247.
15. Hoffman EC, Reyes H, Chu FF, Sander F, Conley LH, Brooks BA and Hankinson O. (1991). Science, 252, 954-958.
16. Huff J, Lucier G and Tritscher A. (1994). Annu. Rev. Pharmacol. Toxicol., 34, 343-372.
17. Jochum W, Passegue E and Wagner EF. (2001). Oncogene, 20, 2401-2412.
18. Knebel A, Rahmsdorf HJ, Ullrich A and Herrlich P. (1996). EMBO J., 15, 5314-5325.
19. Kolluri SK, Weiss C, Koff A and Göttlicher M. (1999). Genes Dev., 13, 1742-1753.
20. Leppä S and Bohmann D. (1999). Oncogene, 18, 6158-6162.
21. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P and Evans R. (1995). Cell, 83, 835-839.
22. Marinissen MJ, Chiariello M and Gutkind JS. (2001). Genes Dev., 15, 535-553.
23. Matikainen T, Perez GI, Jurisicova A, Pru JK, Schlezinger JJ, Ryu HY, Laine J, Sakai T, Korsmeyer SJ, Casper RF, Sherr DH and Tilly JL. (2001). Nat. Genet., 28, 355-360.
24. McLachlan JA. (2001). Endocr. Rev., 22, 319-341.
25. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E and Auricchio F. (1996). EMBO J., 15, 1292-1300.
26. Migliaccio A, Piccolo D, Castoria G, Di Domenico M, Bilancio A, Lombardi M, Gong W, Beato M and Auricchio F. (1998). EMBO J., 17, 2008-2018.
27. Nebert DW. (1994). Biochem. Pharmacol., 47, 25-37.
28. Nebert DW, Puga A and Vasiliou V. (1993). Ann. NY. Acad Sci., 685, 624-640.
29. Noselli S and Perrimon N. (2000). Science, 290, 68-69.
30. Ogawa S, Lozach J, Jepsen K, Sawka-Verhelle D, Perissi V, Sasik R, Rose DW, Johnson RS, Rosenfeld MG and Glass CK. (2004). Proc. Natl. Acad Sci. USA, 101, 14461-14466.
31. Peterson RE, Theobald HM and Kimmel GL. (1993). Crit. Rev. Toxicol., 23, 283-335.
32. Puga A, Nebert DW and Carrier F. (1992). DNA Cell Biol., 11, 269-281.
33. Reyes H, Reisz-Porszasz S and Hankinson O. (1992). Science, 256, 1193-1195.
34. Schmidt JV and Bradfield CA. (1996). Ann. Rev. Cell. Dev. Biol., 12, 55-89.
35. Suskind RR. (1985). Scand. J. Work Environ. Health, 11, 165-171.
36. Swanson HI and Bradfield CA. (1993). Pharmacogenetics, 3, 213-230.
37. van Dam H and Castellazzi M. (2001). Oncogene, 20, 2453-2464.
38. Vanden Heuvel JP and Lucier G. (1993). Environ. Health Perspect., 100, 189-200.
39. Vogt PK. (2001). Oncogene, 20, 2365-2377.
40. Wada T and Penninger JM. (2004). Oncogene, 23, 2838-2849.
41. Weiss C and Bohmann D. (2004). Cell Cycle, 3, 111-113.
42. Weiss C, Kolluri SK, Kiefer F and Göttlicher M. (1996). Exp. Cell Res., 226, 154-163.
43. Weiss C, Schneider S, Wagner EF, Zhang X, Seto E and Bohmann D. (2003). EMBO J., 22, 3686-3695.
44. Werling U, Siehler S, Litfin M, Nau H and Göttlicher M. (2001). Mol. Pharmacol., 59, 1269-1276.
45. Zugerman C. (1990). Dermatol. Clin., 8, 209-213.